Case File №
#VI-2026-0635
PRIVATE
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 5.9 | 5.9 | 5.9 | 24 May 2026 |
| Tirzepatide | X Unrated | 1 | 6.5 | 6.5 | 6.5 | 25 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Adipotide | X N/A | 1 | 4.0 | 2.6 | 2.6 | 2 Apr 2025 |
| Boldenone Cypionate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Botulinum toxin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| BPC-157 Arg Oral | X N/A | 1 | 4.0 | 0.8 | 0.8 | 28 Mar 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Epithalon | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.0 | 0.6 | 0.6 | 2 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 4.0 | 0.5 | 0.5 | 7 May 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| IGF-1 LR3 | X N/A | 1 | 4.0 | 0.2 | 0.2 | 17 Dec 2024 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| Masteron E (Drostanolone E) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 4.0 | 0.7 | 0.7 | 27 Feb 2025 |
| Methylamine hydrochloride CAS 593-51-1 | X N/A | 1 | 4.0 | 0.2 | 0.2 | 28 Mar 2025 |
| MT-1 | X N/A | 1 | 4.0 | 0.4 | 0.4 | 3 Jul 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Pancragen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| PE 22-28 | X N/A | 1 | 4.0 | 0.2 | 0.2 | 3 Jun 2025 |
| Propionyl chloride CAS 79-03-8 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Prostamax | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 1.4 | 1.4 | 27 Feb 2025 |
| S-23 Raw | X N/A | 1 | 4.0 | 1.4 | 1.4 | 8 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X N/A | 1 | 4.0 | 1.5 | 1.5 | 21 May 2025 |
| Stanozolol (Winstrol) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Superdrol | X N/A | 1 | 4.0 | 1.1 | 1.1 | 3 Jun 2025 |
| Tadalafil (Cialis) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Tesofensine | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| Test Enanthate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| TrenMix 200 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Trestolone Acetate (MENT) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| YK-11 Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
Exhibit II
Evidence Log
35 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 5.8 B | 500g | 580.6g | +16.1% | 99.27% | gzf4yj | Lab A | Public |
| 24 May 2026 | GHRP-2 Acetate | 5.2 B | 50mg | 61.3mg | +22.6% | 98.68% | 6thqx2 | Lab C | Community |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 4.1 C | 30mg | 34.3mg | +14.4% | 96.69% | r9ntrv | Lab F | Public |
| 24 May 2026 | Test Enanthate | 5.0 B | 100mg/ml | 95.3mg/ml | -4.7% | 95.64% | zkd4xy | Lab A | Public |
| 24 May 2026 | TrenMix 200 | 4.6 C | 100mg/ml | 86.9mg/ml | -13.1% | 99.72% | hf6oe0 | Lab D | Community |
| 24 May 2026 | Pancragen | 4.0 C | 30mg | 31.9mg | +6.4% | 98.82% | mvaj3x | Lab C | Public |
| 24 May 2026 | BPC-157 Arg Oral | 5.7 B | 100mg | 123.8mg | +23.8% | 99.34% | dfm0ko | Lab D | Public |
| 24 May 2026 | Methylamine hydrochloride CAS 593-51-1 | 4.2 C | 100g | 104.2g | +4.2% | 99.89% | ypcfqy | Lab F | Community |
| 24 May 2026 | S-23 Raw | 4.0 C | 1g | 1.2g | +21.6% | 96.22% | 0snkwk | Lab G | Public |
| 23 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.4 C | 15mg | 14.0mg | -6.4% | 97.02% | m79ts5 | Lab C | Community |
| 20 May 2026 | Botulinum toxin | 5.2 B | 30mg | 26.0mg | -13.2% | 95.01% | 4z97zt | Lab D | Community |
| 19 May 2026 | Halotestin (Fluoxymesterone) | 5.9 B | 25mg | 25.5mg | +2.1% | 98.16% | zl24cd | Lab F | Public |
| 19 May 2026 | HGH 191AA (Somatropin) | 4.0 C | 2mg | 2.3mg | +17.3% | 97.98% | 751wok | Lab C | Community |
| 19 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 C | 15mg | 16.0mg | +6.9% | 97.12% | 8x2ubk | Lab C | Public |
| 19 May 2026 | Masteron P (Drostanolone P) | 4.0 C | 100mg/ml | 101.5mg/ml | +1.5% | 95.79% | rlvmoq | Lab D | Public |
| 17 May 2026 | IGF-1 LR3 | 4.0 C | 30mg | 37.0mg | +23.4% | 98.62% | fwlflw | Lab D | Community |
| 17 May 2026 | Prostamax | 7.1 A | 15mg | 16.0mg | +6.9% | 99.48% | gaj9az | Lab F | Public |
| 9 Jan 2026 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 4.9 C | 100mg/ml | 91.1mg/ml | -8.9% | 95.30% | l5tkwl | Lab G | Public |
| 9 Jan 2026 | Tadalafil (Cialis) | 5.2 B | 100mg | 86.1mg | -13.9% | 97.65% | hxkuim | Lab D | Public |
| 9 Jan 2026 | Thymosin Alpha-1 | 4.0 C | 30mg | 25.5mg | -15.0% | 99.00% | vn67a9 | Lab F | Public |
| 7 Jan 2026 | Masteron E (Drostanolone E) | 4.7 C | 200mg/ml | 239.9mg/ml | +20.0% | 98.07% | zhzlvt | Lab B | Public |
| 6 Jan 2026 | Adipotide | 4.0 C | 20mg | 19.5mg | -2.6% | 96.13% | kcxfj0 | Lab A | Public |
| 29 Dec 2025 | PTD-DBM | 4.0 C | 15mg | 15.2mg | +1.4% | 95.19% | t9zbdf | Lab E | Public |
| 12 Dec 2025 | Stanozolol (Winstrol) Raw | 6.0 A | 500g | 549.2g | +9.8% | 97.97% | kanmj3 | Lab B | Community |
| 17 Nov 2025 | PE 22-28 | 4.9 C | 30mg | 34.7mg | +15.6% | 99.86% | cnu5sx | Lab B | Public |
| 17 Nov 2025 | Trestolone Acetate (MENT) Raw | 4.0 C | 1g | 1.2g | +20.2% | 95.03% | pji5or | Lab B | Public |
| 14 Nov 2025 | MT-1 | 4.0 C | 5mg | 6.2mg | +24.5% | 95.25% | d13r53 | Lab F | Community |
| 14 Nov 2025 | Superdrol | 5.8 B | 25mg | 22.7mg | -9.3% | 97.95% | 6lfw2d | Lab C | Community |
| 5 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.3 C | 20mg | 21.1mg | +5.3% | 96.34% | uisaoz | Lab G | Public |
| 4 Nov 2025 | Propionyl chloride CAS 79-03-8 | 4.2 C | 500g | 453.8g | -9.2% | 95.31% | jhj68b | Lab D | Public |
| 9 Oct 2025 | Epithalon | 4.0 C | 20mg | 23.8mg | +18.9% | 95.97% | 5s2u3w | Lab D | Public |
| 9 Oct 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.4 A | 50mg | 47.9mg | -4.3% | 97.52% | ysksq7 | Lab E | Public |
| 9 Oct 2025 | Tesofensine | 4.0 C | 10mg | 9.8mg | -1.9% | 97.26% | iyhlmk | Lab C | Public |
| 3 Oct 2025 | Boldenone Cypionate | 4.0 C | 250mg/ml | 281.9mg/ml | +12.8% | 95.18% | p9twri | Lab G | Public |
| 3 Oct 2025 | YK-11 Raw | 5.7 B | 5g | 4.7g | -5.2% | 98.94% | scr0gq | Lab D | Public |
— END OF EVIDENCE LOG —